Hip fractures are a major cause of death and disability among older people worldwide, with 70,000 cases every year in the UK, which cost the NHS around GBP2 billion.
[27] reported that incidence of
hip fracture increased four-fold from 2002 to 2007.
This is consistent with the trend that women have lower femur bone strength and higher
hip fracture rates compared to men.
In this study, increased rate of delirium in both the elderly with cognitive impairment and the elderly with
hip fracture surgery may be as a result of this.
Incidence rates were estimated as the number of men and women in 10-year age intervals with at least one
hip fracture in the study year divided by the age- and sex-specific population of the region.
Most patients with
hip fracture are elderly, and their functional reserve and the ability to compensate for physiologic stress are reduced.
For 14 hips in the
hip fracture group, the mean follow-up was 54 (1-143) months.
All randomized or prospective matched controlled trials that assessed the efficacy of bisphosphonate for elderly patients with
hip fracture were included.
Fragility
hip fracture is the most critical complication of osteoporosis.
All patients 65 years of age and older undergoing
hip fracture surgery between the dates of January 2004 and February of 2011 were included in this study.
M2 EQUITYBITES-July 15, 2015-Viking Therapeutics submits IND application to the US FDA to begin clinical development of VK5211 in acute
hip fracture patients